Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Huifeng Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4663-7384; OpenAlex author ID A5100761461. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Multimodal Imaging-Guided Photoimmunotherapy of Pancreatic Cancer by Organosilica Nanomedicine. Co-author DOI 10.1002/adhm.202302195↗
  2. A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy. First author DOI 10.2217/nnm-2019-0063↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lina Song · 2 shared papers, 2019–2024 · strength 0.30
  2. Wenli Qiu · 2 shared papers, 2019–2024 · strength 0.30
  3. Kai Guo · 2 shared papers, 2019–2024 · strength 0.30
  4. Shuai Ren · 2 shared papers, 2019–2024 · strength 0.30
  5. Zhongqiu Wang · 2 shared papers, 2019–2024 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.